Protocol Description 

This study is a 12-week comparison of wound care using a platelet-rich fibrin membrane (CASCADE® Autologous Platelet System) compared to the usual standard treatment for chronic non-healing wounds.

Eligibility Criteria 

You may be eligible to participate in this study if you meet the following criteria: 

• Affected with diabetic foot ulcers 

• Affected with venous leg ulcers 

• Affected with pressure ulcers

Clinical Trial Investigator 

Dr. Jose David Suarez, Principal Investigator